Guangdong Zhongsheng Pharmaceutical Co., Ltd. (002317.SZ)
CNY 10.62
(1.63%)
CNY 10.62
(1.63%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 1.23 Billion CNY | -12.16% |
| 2022 | 1.34 Billion CNY | 9.72% |
| 2021 | 1.22 Billion CNY | 27.6% |
| 2020 | 957.8 Million CNY | -15.38% |
| 2019 | 1.13 Billion CNY | 20.37% |
| 2018 | 940.32 Million CNY | 35.82% |
| 2017 | 692.33 Million CNY | -7.44% |
| 2016 | 747.99 Million CNY | 9.21% |
| 2015 | 684.87 Million CNY | 20.63% |
| 2014 | 567.74 Million CNY | 24.27% |
| 2013 | 456.86 Million CNY | 22.32% |
| 2012 | 373.5 Million CNY | 14.31% |
| 2011 | 326.75 Million CNY | 16.7% |
| 2010 | 279.98 Million CNY | 23.17% |
| 2009 | 227.3 Million CNY | 34.26% |
| 2008 | 169.3 Million CNY | 32.09% |
| 2007 | 128.17 Million CNY | 31.19% |
| 2006 | 97.7 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q3 | 270.25 Million CNY | -27.45% |
| 2024 Q2 | 295.87 Million CNY | 5.56% |
| 2024 Q1 | 280.29 Million CNY | 0.09% |
| 2023 Q4 | 280.04 Million CNY | 11.06% |
| 2023 Q1 | 310.45 Million CNY | -20.32% |
| 2023 FY | 1.17 Billion CNY | -12.16% |
| 2023 Q3 | 252.15 Million CNY | -24.76% |
| 2023 Q2 | 335.14 Million CNY | 7.95% |
| 2022 Q2 | 331.37 Million CNY | 13.59% |
| 2022 FY | 1.34 Billion CNY | 9.72% |
| 2022 Q1 | 291.73 Million CNY | -12.62% |
| 2022 Q4 | 389.62 Million CNY | 18.72% |
| 2022 Q3 | 328.18 Million CNY | -0.96% |
| 2021 Q2 | 313.42 Million CNY | 16.07% |
| 2021 Q3 | 304.85 Million CNY | -2.73% |
| 2021 Q1 | 270.02 Million CNY | -21.96% |
| 2021 FY | 1.22 Billion CNY | 27.6% |
| 2021 Q4 | 333.86 Million CNY | 9.52% |
| 2020 Q4 | 346.01 Million CNY | 26.11% |
| 2020 FY | 957.8 Million CNY | -15.38% |
| 2020 Q1 | 159.43 Million CNY | -56.96% |
| 2020 Q2 | 177.97 Million CNY | 11.63% |
| 2020 Q3 | 274.38 Million CNY | 54.17% |
| 2019 Q3 | 315.05 Million CNY | 23.82% |
| 2019 Q4 | 370.4 Million CNY | 17.57% |
| 2019 FY | 1.13 Billion CNY | 20.37% |
| 2019 Q1 | 191.93 Million CNY | -35.44% |
| 2019 Q2 | 254.45 Million CNY | 32.57% |
| 2018 Q4 | 297.29 Million CNY | 18.4% |
| 2018 Q3 | 251.08 Million CNY | 29.66% |
| 2018 Q2 | 193.65 Million CNY | -2.34% |
| 2018 Q1 | 198.29 Million CNY | -5.17% |
| 2018 FY | 940.32 Million CNY | 35.82% |
| 2017 Q1 | 160.1 Million CNY | -22.26% |
| 2017 FY | 692.33 Million CNY | -7.44% |
| 2017 Q2 | 145.49 Million CNY | -9.13% |
| 2017 Q4 | 209.12 Million CNY | 17.74% |
| 2017 Q3 | 177.61 Million CNY | 22.08% |
| 2016 Q2 | 162.04 Million CNY | -1.72% |
| 2016 Q4 | 205.94 Million CNY | -4.26% |
| 2016 FY | 747.99 Million CNY | 9.21% |
| 2016 Q1 | 164.88 Million CNY | -21.1% |
| 2016 Q3 | 215.11 Million CNY | 32.75% |
| 2015 Q2 | 169.27 Million CNY | 23.97% |
| 2015 Q1 | 136.54 Million CNY | -16.51% |
| 2015 FY | 684.87 Million CNY | 20.63% |
| 2015 Q4 | 208.97 Million CNY | 22.87% |
| 2015 Q3 | 170.08 Million CNY | 0.48% |
| 2014 Q3 | 152.83 Million CNY | 3.25% |
| 2014 FY | 567.74 Million CNY | 24.27% |
| 2014 Q4 | 163.54 Million CNY | 7.01% |
| 2014 Q2 | 148.01 Million CNY | 43.24% |
| 2014 Q1 | 103.33 Million CNY | -18.78% |
| 2013 FY | 456.86 Million CNY | 22.32% |
| 2013 Q1 | 90.81 Million CNY | -15.37% |
| 2013 Q2 | 121.17 Million CNY | 33.43% |
| 2013 Q3 | 117.64 Million CNY | -2.91% |
| 2013 Q4 | 127.22 Million CNY | 8.15% |
| 2012 Q1 | 84 Million CNY | -11.43% |
| 2012 Q2 | 90.1 Million CNY | 7.27% |
| 2012 Q3 | 92.08 Million CNY | 2.19% |
| 2012 FY | 373.5 Million CNY | 14.31% |
| 2012 Q4 | 107.31 Million CNY | 16.54% |
| 2011 Q2 | 81.74 Million CNY | 16.77% |
| 2011 Q4 | 94.83 Million CNY | 18.29% |
| 2011 FY | 326.75 Million CNY | 16.7% |
| 2011 Q1 | 70 Million CNY | -14.82% |
| 2011 Q3 | 80.17 Million CNY | -1.92% |
| 2010 Q1 | 66.78 Million CNY | 10.84% |
| 2010 Q2 | 63.98 Million CNY | -4.2% |
| 2010 FY | 279.98 Million CNY | 23.17% |
| 2010 Q3 | 67.03 Million CNY | 4.78% |
| 2010 Q4 | 82.18 Million CNY | 22.59% |
| 2009 Q1 | 51.22 Million CNY | -3.37% |
| 2009 Q4 | 60.25 Million CNY | -2.2% |
| 2009 Q3 | 61.61 Million CNY | 13.64% |
| 2009 Q2 | 54.21 Million CNY | 5.85% |
| 2009 FY | 227.3 Million CNY | 34.26% |
| 2008 Q4 | 53 Million CNY | 32.58% |
| 2008 FY | 169.3 Million CNY | 32.09% |
| 2008 Q3 | 39.98 Million CNY | 0.0% |
| 2007 FY | 128.17 Million CNY | 31.19% |
| 2006 FY | 97.7 Million CNY | 0.0% |